BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration

Summary by AI BETAClose X

BioNTech announced that CureVac shareholders overwhelmingly approved matters related to BioNTech's exchange offer, with over 99.16% of votes cast in favor. The offer is set to expire on December 3, 2025, at 9:00 a.m. Eastern Time, with CureVac shareholders advised to tender shares by 6:00 p.m. Eastern Time on December 2, 2025. The exchange ratio is 0.05363 of a BioNTech American Depositary Share for each CureVac share, based on BioNTech's volume-weighted average ADS price of $101.88 over the ten trading days ending November 25, 2025. The offer is conditioned on BioNTech acquiring at least 80% of CureVac shares.

Disclaimer*

UK 100

Latest directors dealings